Mental Health Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Depression
Northstar Neuroscience to study cortical stimulation for depression
August 28th, 2006
Northstar Neuroscience, Inc. (NSTR) announced the U. S. Food and Drug Administration has granted approval for the company to conduct a clinical feasibility study of its cortical stimulation therapy system for the treatment of depression. The study will assess the safety and effectiveness of investigational cortical stimulation for patients diagnosed with major depressive disorder who are not responsive to other antidepressant treatments. This is the first study of an implantable cortical stimulation device in depression patients. Up to 12 patients will be studied at the following three sites: the Medical College of Wisconsin in Milwaukee,...
Source: Mental Health Weekly Digest (2006-08-28)
|
